Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Sabin Metal Corporation is a leading global refiner and recycler of precious metals, providing critical support to the pharmaceutical and chemical industries. The company specializes in the recovery of platinum group metals (PGMs) such as palladium, platinum, ruthenium, and rhodium from spent catalysts used in the synthesis of active pharmaceutical ingredients (APIs). By offering sophisticated sampling and refining techniques, Sabin Metal enables life science companies to maximize the value of their catalyst assets while ensuring environmental compliance and resource sustainability. Their services are essential for the cost-effective manufacturing of small molecule drugs that rely on precious metal catalysis.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Sabin Metal.